NCT06380686View on ClinicalTrials.gov

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

November 7, 2024

Primary Completion Date

November 30, 2029

Study Completion Date

November 30, 2030

Conditions
Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the HypopharynxSquamous Cell Carcinoma of the Larynx
Interventions
OTHER

data collection

Demography, Social history, Riskfactors, Relevant medical history, Oncological family history, Disease \& treatment history, Molecular Pathology and Results, Treatment data, Response data, progession free survial, overall survival.

Trial Locations (2)

30161

RECRUITING

Onkologie/Studienzentrum am Raschplatz GbR, Hanover

45147

NOT_YET_RECRUITING

Universitätsklinikum Essen, Essen

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

AIO-Studien-gGmbH

OTHER